vs
Side-by-side financial comparison of Cheche Group Inc. (CCG) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Cheche Group Inc. is the larger business by last-quarter revenue ($32.8M vs $31.1M, roughly 1.1× LIFECORE BIOMEDICAL, INC. \DE\). Cheche Group Inc. runs the higher net margin — 0.5% vs -32.1%, a 32.6% gap on every dollar of revenue.
Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CCG vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $32.8M | $31.1M |
| Net Profit | $153.6K | $-10.0M |
| Gross Margin | 5.7% | 25.0% |
| Operating Margin | — | -9.9% |
| Net Margin | 0.5% | -32.1% |
| Revenue YoY | — | -4.5% |
| Net Profit YoY | — | -52.0% |
| EPS (diluted) | $0.00 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $32.8M | — | ||
| Q3 25 | — | $31.1M | ||
| Q2 25 | $26.0M | — | ||
| Q1 25 | — | $35.2M | ||
| Q4 24 | $18.6M | $32.6M | ||
| Q3 24 | — | $24.7M | ||
| Q2 24 | $36.1M | — | ||
| Q1 24 | — | $35.7M |
| Q1 26 | $153.6K | — | ||
| Q3 25 | — | $-10.0M | ||
| Q2 25 | $-492.4K | — | ||
| Q1 25 | — | $-14.8M | ||
| Q4 24 | $-196.7K | $-6.6M | ||
| Q3 24 | — | $-16.2M | ||
| Q2 24 | $-7.6M | — | ||
| Q1 24 | — | $15.6M |
| Q1 26 | 5.7% | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | 5.2% | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | — | 33.3% |
| Q1 26 | — | — | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | -2.0% | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | -0.3% | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | — | -2.5% |
| Q1 26 | 0.5% | — | ||
| Q3 25 | — | -32.1% | ||
| Q2 25 | -1.9% | — | ||
| Q1 25 | — | -42.0% | ||
| Q4 24 | -1.1% | -20.2% | ||
| Q3 24 | — | -65.7% | ||
| Q2 24 | -21.0% | — | ||
| Q1 24 | — | 43.8% |
| Q1 26 | $0.00 | — | ||
| Q3 25 | — | $-0.29 | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | $-0.00 | $-0.25 | ||
| Q3 24 | — | $-0.53 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.0M | $18.9M |
| Total DebtLower is stronger | $193.3K | $136.0M |
| Stockholders' EquityBook value | — | $-10.5M |
| Total Assets | $203.5M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $20.0M | — | ||
| Q3 25 | — | $18.9M | ||
| Q2 25 | $23.1M | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | $21.1M | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | $28.2M | — | ||
| Q1 24 | — | — |
| Q1 26 | $193.3K | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | $690.0K | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q1 26 | — | — | ||
| Q3 25 | — | $-10.5M | ||
| Q2 25 | $47.1M | — | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | $49.1M | $15.4M | ||
| Q3 24 | — | $-3.9M | ||
| Q2 24 | $48.6M | — | ||
| Q1 24 | — | $17.7M |
| Q1 26 | $203.5M | — | ||
| Q3 25 | — | $235.2M | ||
| Q2 25 | $177.3M | — | ||
| Q1 25 | — | $237.7M | ||
| Q4 24 | $177.7M | $255.4M | ||
| Q3 24 | — | $246.8M | ||
| Q2 24 | $139.3M | — | ||
| Q1 24 | — | $246.2M |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | $-44.7M | — | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $-15.8M | $-6.1M | ||
| Q3 24 | — | $-613.0K | ||
| Q2 24 | $-1.0K | — | ||
| Q1 24 | — | $-1.4M |
| Q1 26 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | $-16.0M | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | $-1.1K | — | ||
| Q1 24 | — | $-7.8M |
| Q1 26 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | -85.9% | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | -0.0% | — | ||
| Q1 24 | — | -21.8% |
| Q1 26 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | 1.2% | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | 17.8% |
| Q1 26 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCG
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
